Related Experiment Video
Updated: Jan 13, 2026
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
A Retrospective Long-Term Follow-Up of the Randomized Study: Total Endoscopic Ablation of Patients With Long-Standing
Anders Wickbom1,2, Espen Fengsrud2,3, Anders Ahlsson2
1Department of Cardiothoracic and Vascular Surgery, Örebro University Hospital, Örebro, SE-70185, Sweden.
Objectives:
Minimally invasive surgical ablation for atrial fibrillation is an alternative to catheter ablation. Achieving a lasting sinus rhythm in long-standing persistent atrial fibrillation is challenging, and long-term data after surgery are limited. In 2016, we published a randomized trial comparing totally endoscopic box lesion ablation of the left atrium (case) to medical therapy (control) during 1 year in patients with long-standing persistent atrial fibrillation. This study presents data from a follow-up of our previous cohort to investigate the rhythm outcome long-term.
Methods:
This was an observational follow-up study. Most recent heart rhythm, time from totally endoscopic ablation to first relapse in atrial fibrillation, re-ablation, stroke, medication, left ventricular ejection fraction, and mortality were gathered from medical records and analysed with descriptive statistics and survival analysis.
Results:
At the end of the randomized trial, 80% of the cases had sinus rhythm without antiarrhythmic drugs. During a mean follow-up of 9 years, 43% of cases and 74% of controls had undergone additional ablation procedures (P = .009). At the last follow-up, 21% of cases and 5% of controls were in SR. After totally endoscopic ablation, the mean time from surgery to first relapse in atrial fibrillation was 23 months (14-31 [95% CI] P < .001).
Conclusions:
In this population of patients with long-standing persistent atrial fibrillation, totally endoscopic box lesion ablation of the left atrium had short-term efficacy in restoring sinus rhythm. Long-term efficacy could not be demonstrated, with a high proportion of relapse in atrial fibrillation beyond 1 year post ablation.
